![]() |
5th International AIDS ConferenceMontreal, Quebec, Canada — Jun 4-9, 1989 |
Int Conf AIDS 1989 Jun 4-9; 5:173 (abstract no. A.576)
Contreras G, Garcia Saiz A, Vallhonrat E, Varela JM, Peres Alvarez L, Najera R; Instituto de Salud Carlos III, Madrid, Spain
OBJECTIVE: - To analyze the seroprevalence of HIV-2 and HTLV-I in Spanish intravenous drug users (IVDA) and the clinical findings of seropositives to HIV-1 in relationships to the antigenemia status. We determine as well -- the incidence of coinfection with other infectious agents.
METHODS: - Sera collected from 4.269 IVDAs were tested (1,888 in 1.987 and 2.381 in 1.988). The presence of anti-HIV-1, -HIV-2, -HTLV-I antibodies was revealed by ELISA. IFA and WB was used as a confirmatory test. -- Antigen ELISA test was used for HIV p24 antigen detection.
RESULTS: - The prevalence of HIV-1 was 64,7% in 1.987 and 61,9% in 1.988. Data collection are ongoing and analysis suggests up to date that a 70% of seropositives still asymptomatic and a 30% shows some pathology related with HIV infection. We are currently performing the seroprevalence of anti-HIV-2 and HTLV-I in a group of IVDAs with statistic significance. A 8% shows HBsAg and a 2,5% active syphilis.
CONCLUSION: - The prevalence rate, about 60% during 1.987 and 1.988 and similar to previous years, is high enough to indicate a serious problem of HIV infection among the Spanish drug users. Very preliminary results indicate no incidence of HIV-2 and HTLV-I in this IVDA population.
890604
A576
Copyright © 1989 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.